Paper: ATRA-Loaded Nanoparticles as Inhalable Host-Directed Immunotherapy for Tuberculosis
Ahmad is a Pharmacist and a PhD student in the group of Prof. Sally-Ann Cryan at the Royal College of Surgeons in Ireland (RCSI) – School of Pharmacy and biomolecular sciences. In 2019, he received the Strategic Academic Recruitment (StAR) PhD scholarship from the Royal College of Surgeons in Ireland. His PhD work focuses on developing inhalable All Trans Retinoic Acid-loaded nanoparticles as host directed immunotherapy for tuberculosis in collaboration with St. James’ hospital (Trinity College Dublin), Imperial College London and Aerogen Ltd.
He completed his Erasmus Mundus Joint Master’s degree in Nanomedicine for drug delivery (NANOMED EMJMD) jointly from four universities; University of Paris and University of Angers in France, University of Pavia in Italy and University of Patras in Greece, funded by Erasmus+ scholarship. He did his Master’s thesis at Queen’s university Belfast in United Kingdom focusing on engineering targeted nanomedicines for advanced prostate cancer. He obtained his BSc in Pharmacy from the University of Jordan in 2016.
In addition to his PhD work, Ahmad has helped is supervising many undergrad and postgrad thesis students. Also, he is currently carrying out three collaborations with different institutes in Ireland and abroad focusing on developing and scaling up formulations for many fundamental and translational applications. He presented his work in many national and international meetings.